CardieX Ltd., a global health technology company focused on cardiovascular disease, has bought Blumio Inc., a Silicon Valley-based developer of algorithms and technology for cardiovascular sensors.

Blumio develops wearable sensor technologies that are able to capture cardiovascular signals without the use of pulse pressure. Blumio’s technology looks to improve clinical performance for CardieX’s heart health monitoring service offerings. Blumio CEO and co-founder, Catherine Liao, joins CardieX as chief strategy officer, with Blumio’s head of product and operations Steve Braaten joining CardieX as operations director.

“Blumio brings a suite of capabilities in wearable sensor development, signal processing, and big data analytics expertise that will benefit both of our ATCOR and CONNEQT brands, especially in relation to the ongoing development activities surrounding our CONNEQT Band,” states Craig Cooper, CardieX Group CEO. “This acquisition is a natural extension of our core solutions that provide a comprehensive ecosystem of unique health and wellness features focused on heart health.”